65. Meremo A., Mshana S.E., Kidenya B.R., Kabangila R., Peck R., Kataraihya J.B. High prevalence of non-typhoid Salmonella bacteraemia among febrile HIV adult patients admitted at a tertiary hospital, north-western Tanzania // Int Arch Med. 2012. V. 5. № 1. P. 28--34.
66. Reddy E.A., Reddy E.A., Shaw A.V., Crump J.A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis // Lancet Infect Dis. 2010. V. 10. № 6. P. 417--432.
67. Tabu C., Breiman R.F., Ochieng B., Aura D., Cosmas L., Audi A., Olack D., Bigogo G., Ongus J.R., Fields P., Mintz E., Burton D., Oundo J., Feikin D.R. Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya // PLoS One. 2012. V. 7. № 2. e31237.
68. Japiassu A.M., Amancio R.T., Mesquita E.C., Medeiros D.M., Bernal H.B., Nunes E.P., Luz P.M., Grin- sztejn B., Bozza F.A. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients // Crit Care. 2010. V. 14. № 4. P. 152.
69. Uhlenkott M.C., Buskin S.E., Kahle E.M., Barash E., Aboulafia D.M. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King County adult/ adolescent spectrum of HIV- related diseases project // Am J Med Sci. 2008. V. 336. № 3. P. 217--223.
70. Ramsetty S.K., Stuart L.L., Blake R.T., Parsons C.H., Salgado C.D. Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection // HIV Med. 2010. V. 11. № 6. P. 389--394.
71. Crum-Cianflone N.F., Burgi A.A., Hale R.B. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons // Int J STD AIDS. 2007. V. 18. № 8. P. 521--526.
72. Gaskell K.M., Feasey N.A., Heyderman R.S. Management of severe non-TB bacterial infection in HIV-infected adults // Expert Rev Anti Infect Ther. 2015. V. 13. № 2. P. 183--195.
73. Karp C.L., Auwaerter P.G. Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens // Clin Infect Dis. 2007. V. 45. № 9. P. 1214--1220.
74. Fortanier A.C., Venekamp R.P., Boonacker C.W., Hak E., Schilder A.G., Sanders E.A., Damoiseaux R.A. Pneumococcal conjugate vaccines for preventing otitis media // Cochrane Database Syst Rev. 2014. V. 4. CD001480.
75. Nascimento-Carvalho C.M., Ribeiro C.T., Cardoso M.R., Barral A., Araujo-Neto C.A., Oliveira J.R., Sobral L.S., Viriato D., Souza A.L., Saukkoriipi A., Paldanius M., Vainionpaa R., Leinonen M., Ruuskanen O. The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country // Pediatr Infect Dis J. 2008. V. 27. № 10. P. 939--941.
76. Peltola V.T., McCullers J.A. Respiratory viruses predisposing to bacterial infections: role of neuraminidase // Pediatr Infect Dis J. 2004. V. 23. Suppl 1. P. 87--97.
77. Carbonell-Estrany X., Simoes E.A., Dagan R., Hall C.D., Harris B., Hultquist M., Connor E.M., Losonsky G.A., Motavizumab Study Group. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial // Pediatrics. 2010. V. 125. № 1. P. 35--51.
78. Nair N., Biswas R., Gotz F., Biswas L. Impact of Staphylococcus aureus on pathogenesis in polymicrobial infections // Infect Immun. 2014. V. 82. № 6. P. 2162-- 2169.
79. Bassetti M., Ginocchio F., Mikulska M. New treatment options against gram-negative organisms // Crit Care. 2011. V. 15. № 2. P. 215--223.
80. Ciofi Degli A.M., Bernaschi P., Carletti M., Luzzi I., Garcia-Fernandez A., Beryaina A., Sisyo A., Locatelli F., Raponi M. An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy // BMC Infect Dis. 2014. V. 14. P. 494--501.
81. Hraiech S., Hiblot J., Lafleur J., Lepidi H., Papazian L., Rolain J.M., Raoult D., Elias M., Silby M.W., Bzdren- ga J., Bregeon F., Chabriere E. Inhaled lactonase reduces Pseudomonas aeruginosa quorum sensing and mortality in rat pneumonia // PLoS One. 2014. V. 9. № 10. e107125.
82. Крылов С.В., Кропински А.М., Плетенева Е.А., Шабурова О.В., Буркальцева, М.В., Мирошников К.А., Крылов В.Н. Свойства нового D3 подобного бактериофага phiPMGl Pseudomonas aeruginosa: структура генома и перспективы использования фага в фаготерапии // Генетика. 2012. Т. 48. № 9. C. 1057--1067.
83. Mukherjee S., Brothers K.M., Shanks R.M., Kadouri E. Visualizing Bdellovibrio bacteriovogus by using the tdTomato Fluprescent Protein // Appl Environ Microbiol. 2015. V. 82. № 6. P. 1653--1661.
84. Spain E.M., Nrnez M.E., Kim H.J., Taylor R.J., Thomas N., Wengen M.B., Dalleska N.F., Bromley J.P., Schermerhom K.H., Ferguson M.A. Idenyification and differential production of ubiquinon-8 in the bacterial predator Bdellovibrio bacteriovorus // Res Microbiol. 2016. V. 167. № 5. P. 413--423.
85. Скулачев В.П., Богачев А.В., Каспаринский Ф.О. Мембранная биоэнергетика. М.: Издательство Московского университета. 2010. 368 с.
86. Zelaya H., Alvarez S., Kitazawa H., Villena J. Respiratory antiviral immunity and immunobiotics: beneficial effects on inflammation-coagulation interaction during influenza virus infection // Front immunol. 2016. V. 7. P. 633--648.
87. Villena J., Saavedra L., Hebert E.M., Masumizu Y., Sato N., Humayun Kober A.K., Albarracin L., Clua P., Ikeda-Ohtsubo W., Kitazawa H. Draft genome sequence of Lactobacillus plantarum MPL16, a wakame-utilizing immunobiotic strain isolated from swine feces // Genome Announc. 2017. V. 5. № 10. e00006-17.
88. Rynda-Apple A., Robinson K.M., Alcorn J.F. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease // Infect Immun. 2015. V. 83. № 10. P. 3764--3770.